Dr. Amit R. Patel

Hospital Medicine
622 W 168th St, 
New York, NY 
622 W 168th St, 
New York, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Amit Patel is a Hospital Medicine provider in New York, New York. Dr. Patel is rated as an Experienced provider by MediFind in the treatment of Paroxysmal Supraventricular Tachycardia (PSVT). His top areas of expertise are Paroxysmal Supraventricular Tachycardia (PSVT), Heart Failure with Preserved Ejection Fraction (HFpEF), Fractured Spine, Tissue Biopsy, and Carotid Artery Surgery.

His clinical research consists of co-authoring 292 peer reviewed articles and participating in 12 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hospital Medicine
Hospital Affiliations
Lincoln Medical & Mental Health Center
New York-Presbyterian Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
622 W 168th St, New York, NY 10032

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

12 Clinical Trials

Surveillance HeartCare® Outcomes Registry
Surveillance HeartCare® Outcomes Registry
Enrollment Status: Active_not_recruiting
Publish Date: January 21, 2026
Intervention Type: Other
Use of a Multiplexed Molecular Biomarker Test Cxbladder, in Real World Decision Making to Provide Clinical Utility Using a Randomized Design (STRATA Study)
Use of a Multiplexed Molecular Biomarker Test Cxbladder, in Real World Decision Making to Provide Clinical Utility Using a Randomized Design (STRATA Study)
Enrollment Status: Completed
Publish Date: May 31, 2025
Intervention Type: Diagnostic test
Study Phase: Not Applicable
Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue in an Intermediate-Risk Patient Population
Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue in an Intermediate-Risk Patient Population
Enrollment Status: Completed
Publish Date: February 12, 2025
Intervention Type: Device
Study Phase: Not Applicable
The RADIANCE-HTN Study. A Study of the ReCor Medical Paradise System in Clinical Hypertension
The RADIANCE-HTN Study. A Study of the ReCor Medical Paradise System in Clinical Hypertension
Enrollment Status: Active_not_recruiting
Publish Date: June 28, 2024
Intervention Type: Device
Study Phase: Not Applicable
Randomized, Double-Blind, Placebo-Controlled Phase I/II Study of the Safety and Efficacy of Intracoronary Delivery of Allogeneic Cardiosphere-Derived Cells in Patients With a Myocardial Infarction and Ischemic Left Ventricular Dysfunction
Randomized, Double-Blind, Placebo-Controlled Phase I/II Study of the Safety and Efficacy of Intracoronary Delivery of Allogeneic Cardiosphere-Derived Cells in Patients With a Myocardial Infarction and Ischemic Left Ventricular Dysfunction
Enrollment Status: Terminated
Publish Date: April 09, 2024
Intervention Type: Biological, Drug
Study Phase: Phase 1/Phase 2
Early Feasibility Study for the Foldax Tria Aortic Heart Valve
Early Feasibility Study for the Foldax Tria Aortic Heart Valve
Enrollment Status: Active_not_recruiting
Publish Date: September 13, 2023
Intervention Type: Device
Study Phase: Not Applicable
A Phase III, Multicenter, Randomized Controlled Study to Compare Safety and Efficacy of a Haploidentical HSCT and Adjunctive Treatment With ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted ex Vivo of Host Alloreactive T-cells, Versus a Haploidentical HSCT With Post-transplant Cyclophosphamide in Patients With a Hematologic Malignancy
A Phase III, Multicenter, Randomized Controlled Study to Compare Safety and Efficacy of a Haploidentical HSCT and Adjunctive Treatment With ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted ex Vivo of Host Alloreactive T-cells, Versus a Haploidentical HSCT With Post-transplant Cyclophosphamide in Patients With a Hematologic Malignancy
Enrollment Status: Terminated
Publish Date: May 24, 2022
Intervention Type: Drug, Biological, Procedure
Study Drugs: ATIR101 Ex Vivo-Depleted T Lymphocyte-Enriched Leukocyte, Cyclophosphamide
Study Phase: Phase 3
Cardiovascular Complications of Sickle Cell Disease
Cardiovascular Complications of Sickle Cell Disease
Enrollment Status: Completed
Publish Date: February 23, 2022
Intervention Type: Procedure
Stress Testing and Cardiac Magnetic Resonance
Stress Testing and Cardiac Magnetic Resonance
Enrollment Status: Completed
Publish Date: July 12, 2021
Intervention Type: Drug
Study Phase: Phase 4
Comprehensive Evaluation of Patients With Chest Pain Using Cardiac Computed Tomography: Value of Adding Regadenoson Stress Perfusion Imaging to Noninvasive Coronary Angiography
Comprehensive Evaluation of Patients With Chest Pain Using Cardiac Computed Tomography: Value of Adding Regadenoson Stress Perfusion Imaging to Noninvasive Coronary Angiography
Enrollment Status: Completed
Publish Date: February 21, 2021
Intervention Type: Drug
Study Phase: Not Applicable
Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM
Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM
Enrollment Status: Completed
Publish Date: January 11, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Double Blind, Placebo-controlled Study to Assess the Anti-viral Effect, Safety and Tolerability of Inhaled PC786 for the Treatment of Acute Respiratory Syncytial Virus (RSV) Infection in Adult Hematopoietic Stem Cell Transplant Recipients
A Double Blind, Placebo-controlled Study to Assess the Anti-viral Effect, Safety and Tolerability of Inhaled PC786 for the Treatment of Acute Respiratory Syncytial Virus (RSV) Infection in Adult Hematopoietic Stem Cell Transplant Recipients
Enrollment Status: Terminated
Publish Date: June 12, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 11 Less Clinical Trials

292 Total Publications

2025 ACC/AHA/ASE/ASNC/SCCT/SCMR Advanced Training Statement on Advanced Cardiovascular Imaging: A Report of the ACC Competency Management Committee.
2025 ACC/AHA/ASE/ASNC/SCCT/SCMR Advanced Training Statement on Advanced Cardiovascular Imaging: A Report of the ACC Competency Management Committee.
Journal: Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance
Published: November 20, 2025
Similar Doctors
Peter Roytman
Distinguished in Paroxysmal Supraventricular Tachycardia (PSVT)
Dr. Peter Roytman
Hospital Medicine
Distinguished in Paroxysmal Supraventricular Tachycardia (PSVT)
Dr. Peter Roytman
Hospital Medicine

Practice Associates Medical Group

100 Madison Ave, 
Morristown, NJ 
 (27.7 miles away)
973-971-5596
Languages Spoken:
English
See accepted insurances

Peter Roytman is a Hospital Medicine provider in Morristown, New Jersey. Dr. Roytman is rated as an Advanced provider by MediFind in the treatment of Paroxysmal Supraventricular Tachycardia (PSVT). His top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Paroxysmal Supraventricular Tachycardia (PSVT), Atrioventricular Nodal Reentrant Tachycardia (AVNRT), Pacemaker Implantation, and Atherectomy.

Distinguished in Paroxysmal Supraventricular Tachycardia (PSVT)
Dr. Asad Mohammad
Cardiac Electrophysiology | Cardiology | Hospital Medicine
Distinguished in Paroxysmal Supraventricular Tachycardia (PSVT)
Dr. Asad Mohammad
Cardiac Electrophysiology | Cardiology | Hospital Medicine

Middletown Medical PC

111 Maltese Dr, 
Middletown, NY 
 (48.4 miles away)
845-342-4774
Experience:
17+ years
Languages Spoken:
English
See accepted insurances

Asad Mohammad is a Cardiac Electrophysiologist and a Cardiologist in Middletown, New York. Dr. Mohammad has been practicing medicine for over 17 years and is rated as a Distinguished provider by MediFind in the treatment of Paroxysmal Supraventricular Tachycardia (PSVT). His top areas of expertise are Paroxysmal Supraventricular Tachycardia (PSVT), His Bundle Tachycardia, Atrioventricular Nodal Reentrant Tachycardia (AVNRT), Pacemaker Implantation, and Cardiac Ablation.

Experienced in Paroxysmal Supraventricular Tachycardia (PSVT)
Dr. Punit R. Jariwala
Hospital Medicine
Experienced in Paroxysmal Supraventricular Tachycardia (PSVT)
Dr. Punit R. Jariwala
Hospital Medicine

Punit R Jariwala MDoffice

300 2nd Avenue, Suite G101, 
Long Branch, NJ 
 (37.2 miles away)
908-376-3823
Languages Spoken:
English
See accepted insurances

Punit Jariwala is a primary care provider, practicing in Hospital Medicine in Long Branch, New Jersey. Dr. Jariwala is rated as an Advanced provider by MediFind in the treatment of Paroxysmal Supraventricular Tachycardia (PSVT). His top areas of expertise are Hypertensive Heart Disease, Ascites, End-Stage Renal Disease (ESRD), Colonoscopy, and Endoscopy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Patel's expertise for a condition
ConditionClose
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile